CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Sweden

2018-02-05
Price :
Published : Feb-2018
No. of Pages : 133
Table of Contents
Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porter's Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix

List of Tables
Table 1: Pharmaceutical Market, Sweden, Sales of Patented Drug Products by Major Therapeutic Class ($m), 2016 21
Table 2: Medical Device Market, Sweden, Revenue by Segment 44
Table 3: IVD Devices Market, Sweden, Revenue and Market Share of Major Players 45
Table 4: Ophthalmic Devices Market, Sweden, Revenue and Market Share of Major Players 46
Table 5: Cardiovascular Devices Market, Sweden, Revenue and Market Share of Major Players 47
Table 6: Healthcare IT Market, Sweden, Revenue and Market Share of Major Players 48
Table 7: Orthopedic Devices Market, Sweden, Revenue and Market Share of Major Players 49
Table 8: Benefits Associated with SSIA, Sweden 83
Table 9: Pricing of Medicines at Different Levels, Sweden 85
Table 10: Application Type and Fees, 2017, Sweden 88
Table 11: Annual Fees, 2017, Sweden 88
Table 12: Patent Fees, 2017, Sweden 100
Table 13: Trademark Fees, 2017, Sweden 103
Table 14: Advertising Regulation, 2017, Sweden 105
Table 15: Advertising of pharmaceutical products through other mass media, 2017, Sweden 105
Table 16: Label of a pharmaceutical product, Sweden, 2017 106
Table 17: Trade Associations, Sweden 117
Table 18:Trade Fairs, Sweden 118

List of Figures
Figure 1: Pharmaceutical Market, Sweden, Revenue, 2009-2016 8
Figure 2:Medical Device Market, Sweden, Revenue , 2009-2016 8
Figure 3: Pharmaceutical Market Share (Segments), Sales, 2015 8
Figure 4: Number of Deals (2016-2017) 12
Figure 5: 2016-17 Deal Overview By Region 12
Figure 6: Country Profile, Sweden, 2017 14
Figure 7: Pharmaceutical Market, Sweden, Revenue, 2009-2016 16
Figure 8: Pharmaceutical Market, Sweden, Revenue Forecast , 2017-2021 16
Figure 9: Pharmaceutical Market, Sweden, Pharmaceutical Exports 17
Figure 10: Pharmaceutical Market, Sweden, Top Export Partners 17
Figure 11: Pharmaceutical Market, Sweden, Pharmaceutical Imports 18
Figure 12: Pharmaceutical Market, Sweden, Top Import Partners 18
Figure 13: Pharmaceutical Market, Sweden, Supply Channels 19
Figure 14: Pharmaceutical Market, Sweden, Sales of Patented Drug Products by Major Therapeutic Class, 2016 21
Figure 15: Pharmaceutical Market, Sweden, Major Players 23
Figure 16: Medical Device Market, Sweden, Revenue 43
Figure 17: Medical Device Market, Sweden, Revenue Forecast 43
Figure 18: Medical Device Market, Sweden, Revenue by Segment 44
Figure 19: In vitro Diagnostics Market, Sweden, Revenue 45
Figure 20: In vitro Diagnostics Market, Sweden, Market Share of Major Players 45
Figure 21: Ophthalmic Devices Market, Sweden, Revenue 46
Figure 22: Ophthalmic Devices Market, Sweden, Market Share of Major Players 46
Figure 23: Cardiovascular Devices Market, Sweden, Revenue 47
Figure 24: Cardiovascular Devices Market, Sweden, Market Share of Major Players 47
Figure 25: Healthcare IT Market, Sweden, Revenue 48
Figure 26: Healthcare IT Market, Sweden, Market Share of Major Players 48
Figure 27: Orthopedic Devices Market, Sweden, Revenue 49
Figure 28: Orthopedic Devices Market, Sweden, Market Share of Major Players 49
Figure 29: Diagnostic Market, Sweden, Revenue , 2009-2016 50
Figure 30: Diagnostic Market, Sweden, Revenue Forecast , 2017-2021 50
Figure 31: Medical Device Market, Sweden, Revenue of Major Players 52
Figure 32: Deal Value and Deal Count, Pharmaceutical Market, Sweden, 2016-2017 72
Figure 33: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Sweden, 2016-2017 72
Figure 34:Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Sweden, 2016-2017 72
Figure 35: Top Five Therapy Area by Deal value, Pharmaceutical Market, Sweden, 2016-2017 73
Figure 36: Top Five Therapy Area by Deal number, Pharmaceutical Market, Sweden, 2016-2017 73
Figure 37: M&A Deals by Therapy Area, Pharmaceutical Market, Sweden, 2016-2017 (by value and by number) 73
Figure 38: Venture Financing Deals by Therapy area, Pharmaceutical Market, Sweden, 2016-2017 (by value and by number) 73
Figure 39: Medical Device Market Deals, Sweden, 2016 - 2017 (By deal value, $ m) 74
Figure 40: Medical Device Market Deals, Sweden, 2016 - 2017 (By deal Count) 74
Figure 41: Medical Device Market deals share (by deal count), Sweden, 2016 - 2017 74
Figure 42: Medical Device Market deals share (by deal value), Sweden, 2016 - 2017 74
Figure 43: Top 5 therapy area by deal value, Medical Device, Sweden, 2016-2017 75
Figure 44: Top 5 therapy area by deal number, Medical Device, Sweden, 2016- 2017 75
Figure 45: M&A deals by therapy area, Medical Device, Sweden, 2016-2017 (By value and by number) 75
Figure 46: Venture Financing deals by therapy area, Medical Device, Sweden, 2016-2017 (By value and by number) 75
Figure 47: Private Equity deals by therapy area, Medical Device Sweden, 2016- 2017 (By value and by number) 75
Figure 48: Healthcare System, Sweden 80
Figure 49: Drug Funding and Reimbursement Approval Process, Sweden 81
Figure 50: Financial Flow, Sweden 82
Figure 51: Out-of-Pocket Expenditure (% of total expenditure on health) 84
Figure 52: Pharmaceutical and Consumer Price Index 84
Figure 53: Medical Products Agency, Organization Chart, Sweden 86
Figure 54: New Drug Approval Process, Sweden 87
Figure 55: Centralized Procedure, 2017, Sweden 89
Figure 56: Decentralized Procedure, 2017, Sweden 90
Figure 57: Mutual Recognition Procedure, 2017, Sweden 91
Figure 58: Conformity Assessment of Class I Medical Devices, EU, 2017 93
Figure 59: Conformity Assessment of Class IIa Medical Devices, EU, 2017 94
Figure 60: Conformity Assessment of Class IIb Medical Devices, EU, 2017 95
Figure 61: Conformity Assessment of Class III Medical Devices, EU, 2017 96
Figure 62: European Patent Approval Process, EU, 2017 101
Figure 63: Unitary Patent Approval Process, EU, 2017 102
Figure 64: Clinical Trial Process, Sweden, 2017 104
Figure 65: Number of Hospitals, Sweden, 2009-2016 109
Figure 66: Hospital Beds (per 1,000 population), Sweden 110
Figure 67: Acute Care Hospital Beds (per 1,000 population), Sweden 110
Figure 68: Psychiatric Hospital Beds (per 1,000 population), Sweden 110
Figure 69: Life Expectancy, 2009-2015, Sweden 111
Figure 70: Immunization Rate (%), 2009-2016, Sweden 111
Figure 71: PM2.5 (?g per m3), Sweden, 2009-2015 112
Figure 72: CO2 Emissions (million tons), Sweden, 2009-2015 112
Figure 73: Physicians (per 1,000 population), Sweden, 2009-2015 113
Figure 74: Nurses (per 1,000 population), Sweden, 2009-2015 113
Figure 75: Dentists (per 1,000 population), Sweden, 2009-2015 113
Figure 76: Pharmacists (per 1,000 population), Sweden, 2009-2015 113
Figure77: Major Causes of Mortality (per 100,000 population), Sweden, 2015 114
Figure78: Major Causes of Male Mortality, Sweden, 2015 114
Figure 79: Major Causes of Female Mortality, Sweden, 2015 114
Figure 80: Disability-Adjusted Life Years by Major Disease (‘000), Sweden, 2015 114
Figure 81: Healthcare Expenditure as Percentage of GDP (%), Sweden, 2009-2016 115
Figure 82: Public-Private Share (%), Sweden, 2009-2015 115
Figure 83: Major Components of Healthcare Spending (%), Sweden, 2016 116
Figure 84: Opportunities & Challenges, Sweden 120
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData